NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress
National Cancer Control Plans can and should include regionally appropriate guidelines according to abstracts presented by the National Comprehensive Cancer Network during global event hosted by the Union of International Cancer Control. PLYMOUTH MEETING, Pa. and HONG KONG, Sept. 24, 2026 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading...
Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate ‘Bersiporocin’ at ERS 2026
104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion Study includes both antifibrotic-treated and untreated patients; top-line data expected in H1 2027 First-in-class PRS inhibitor being developed as a potential new therapeutic option for IPF BARCELONA, Spain...
CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care ROCHESTER, N.Y., Sept. 23, 2026 /PRNewswire/ -- CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced six major product advancements that have been accelerated to launch...
Basecamp Research raises $140M to advance AI-designed therapeutics
Oversubscribed Series C led by S32 with backing from NVIDIA and others Funding will advance a pipeline of EDEN-designed therapeutics, starting with in vivo cell therapy, and expand pharmaceutical partnerships The company has demonstrated strong preclinical results across multiple modalities and disease areas LONDON and BOSTON, Sept. 23, 2026 /PRNewswire/ --...
Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent
FDA Clearance and CE Mark Complete Aptiva's Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing SAN DIEGO, Sept. 23, 2026 /PRNewswire/ -- Werfen today announced that its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin A (IgA) Reagent has received both U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark under the European Union's In Vitro...
From Advice to Action: How Ping An Good Doctor Is Bringing Healthcare AI into the Real World
HONG KONG, Sept. 23, 2026 /PRNewswire/ -- Most healthcare AI tools can analyze symptoms and suggest a care plan, but far fewer can help patients follow through. The gap appears both when people try to maintain proper form during a home workout and when they must navigate an unfamiliar hospital in another language. This distance between digital advice...
Angel Yeast’s Angeopro™ Yeast Protein Achieves Dual International Certifications
Setting a New Standard in High-Quality Nutrition SHANGHAI, Sept. 23, 2026 /PRNewswire/ -- Angeopro™ Yeast Protein range F80, F84, Hi90-A, and S80-A, developed by Angel Yeast (SSE: 600298), recently received Monash University Low FODMAP CertifiedTM status. Angeopro™ Yeast Protein products manufactured by Angel Yeast (Yichang High-Tech Zone) Co., Ltd received the...
HKSH Medical Group and United Imaging Mark Launch of Hong Kong’s First Long-Axial PET/CT
HONG KONG, Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI Panorama GS, at HKSH Cancer Centre, providing a new technology platform for molecular imaging clinical applications and research in Hong Kong. HKSH Medical Group (HKSH)...
Leedon Technology Expands Healthcare Technical Capabilities with Authorised IMT Analytics Service Centre in Singapore
The new service centre builds on more than two decades of healthcare industry experience, expanding local calibration and technical support for medical gas flow devices and analysers SINGAPORE, Sept. 23, 2026 /PRNewswire/ -- Leedon Technology Pte Ltd, a Singapore-based healthcare solutions provider, has expanded its technical service capabilities with the opening of an Authorised Service Centre for IMT...
Innovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting
SAN FRANCISCO and SUZHOU, China, Sept. 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that clinical data for its IBI363/TAK-928 (PD-1/IL-2α-biased bispecific fusion protein) * , IBI343/TAK-921 (Arcotatug Tavetecan, CLDN18.2 ADC)...
